Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Home
»
Analysts
»
Steve McGarry
Steve McGarry
Stock Analyst at HSBC
(n/a)
# 4,350
Out of 4,711 analysts
4
Total ratings
n/a
Success rate
-29.31%
Average return
Main Sectors:
Healthcare
Top Industries:
Drug Manufacturers - General
Stocks Rated by Steve McGarry
Stock
Action
Price Target
Current
Upside
Ratings
Updated
GRFS
Grifols
Upgrades:
Buy
n/a
$7.51
-
2
Mar 11, 2021
SNY
Sanofi
Upgrades:
Hold
n/a
$47.71
-
2
Aug 30, 2017
GRFS
Grifols
Mar 11, 2021
Upgrades:
Buy
Price Target:
n/a
Current: $7.51
Upside: -
2 Ratings
View All
SNY
Sanofi
Aug 30, 2017
Upgrades:
Hold
Price Target:
n/a
Current: $47.71
Upside: -
2 Ratings
View All